Biotech News
Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals
ir.corcept.com2026-05-06 15:28 EST
REDWOOD CITY, Calif. --(BUSINESS WIRE)--Feb. 19, 2026-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the